Haematological trials

We run holistic and complex commercial and non-commercial clinical trials from Phase 1 to Phase 4 in a world class academic and clinical partnership. Our globally recognised clinicians are responsible for trials that are driving cutting-edge novel treatments that advance cancer treatment and care.

Case study: MonumenTAL-6

A study comparing the effectiveness of the drugs Tal-pomalidomide (Tal-P) or Tal-Tec when taken in combination with others to treat blood cancer.